Citations (113)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (39)
Yuqi Xiong, Youwen Cui & Xinping Zhang. (2022) Pharmaceutical expenditure and total health-care expenditure in OECD countries and China: bidirectional Granger causality on the basis of health level. Expert Review of Pharmacoeconomics & Outcomes Research 22:3, pages 505-512.
Read now
Read now
Julius C Mwita, Olayinka O Ogunleye, Adesola Olalekan, Aubrey C Kalungia, Amanj Kurdi, Zikria Saleem, Jacqueline Sneddon & Brian Godman. (2021) Key Issues Surrounding Appropriate Antibiotic Use for Prevention of Surgical Site Infections in Low- and Middle-Income Countries: A Narrative Review and the Implications. International Journal of General Medicine 14, pages 515-530.
Read now
Read now
Kyriakos Souliotis, Christina Golna, Chara Kani & Sophia Markantonis. (2019) Exploring knowledge and perceptions on generic drugs of final year pharmacy school students in Greece. Expert Review of Pharmacoeconomics & Outcomes Research 19:5, pages 569-574.
Read now
Read now
Holly McCabe, Brian Godman, Amanj Kurdi, Katie Johnston, Sean MacBride-Stewart, Janey Lennon, Simon Hurding, Marion Bennie & Alec Morton. (2019) Prescribing trends of inhaler treatments for asthma and chronic obstructive pulmonary disease within a resource-constrained environment in the Scottish national health service: findings and implications. Expert Review of Respiratory Medicine 13:7, pages 679-689.
Read now
Read now
Zorica Naumovska, Aleksandra K Nestorovska, Aleksandra Grozdanova, Kristina Hristova, Aleksandar Dimovski, Ljubica Suturkova & Zoran Sterjev. (2018) Evaluation of statin utilization in the Republic of Macedonia during 2013–2016. ClinicoEconomics and Outcomes Research 10, pages 339-347.
Read now
Read now
Axel Leporowski, Brian Godman, Amanj Kurdi, Sean MacBride-Stewart, Margaret Ryan, Simon Hurding, Renata CRM Do Nascimento, Marion Bennie & Alec Morton. (2018) Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish national health service: influence and implications. Expert Review of Pharmacoeconomics & Outcomes Research 18:6, pages 655-666.
Read now
Read now
R. C. R. M. do Nascimento, A. A. Guerra Jr.J. Alvares, I. C. Gomes, B. Godman, M. Bennie, A. B. Kurdi & F. A. de Acurcio. (2018) Statin use in Brazil: findings and implications. Current Medical Research and Opinion 34:10, pages 1809-1817.
Read now
Read now
Marjolein Engelkes, Jan C. van Blijderveen, Jetty A. Overbeek, Josephine Kuiper, Ron C. M. Herings, Miriam C. J. M. Sturkenboom, Johan C. de Jongste, Katia M. C. Verhamme & Hettie M. Janssens. (2018) Brand and generic use of inhalation medication and frequency of switching in children and adults: A population-based cohort study. Journal of Asthma 55:10, pages 1086-1094.
Read now
Read now
Joseph O. Fadare, Kazeem A. Oshikoya, Olayinka O. Ogunleye, Olufemi O. Desalu, Alessandra Ferrario, Okezie O. Enwere, Adekunle Adeoti, Taofiki A. Sunmonu, Amos Massele, Amanj Baker & Brian Godman. (2018) Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications. Hospital Practice 46:2, pages 77-87.
Read now
Read now
Vafa Abilova, Amanj Kurdi & Brian Godman. (2018) Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications. Expert Review of Anti-infective Therapy 16:1, pages 77-84.
Read now
Read now
Loc Phuoc Thai, Agnes Isabelle Vitry & John Robert Moss. (2018) Price and utilisation differences for statins between four countries. Expert Review of Pharmacoeconomics & Outcomes Research 18:1, pages 71-81.
Read now
Read now
Brian Godman & Joseph Fadare. (2017) Non-guideline-recommended prescribing of proton pump inhibitors: implications for the future and reducing over usage. Current Medical Research and Opinion 33:11, pages 2085-2087.
Read now
Read now
Peslie G Ngambi, Aubrey C Kalungia, Michael R Law, Francis Kalemeera, IIse Truter, Brian Godman & Derick Munkombwe. (2017) Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa. Expert Review of Pharmacoeconomics & Outcomes Research 17:5, pages 459-467.
Read now
Read now
Amos Massele, Johanita Burger, Francis Kalemeera, Mary Jande, Thatayaone Didimalang, Aubrey Chichonyi Kalungia, Kidwell Matshotyana, Michael Law, Brighid Malone, Olayinka Ogunleye, Margaret Oluka, Bene D Paramadhas, Godfrey Rwegerera, Sekesai Zinyowera & Brian Godman. (2017) Outcome of the second Medicines Utilisation Research in Africa Group meeting to promote sustainable and appropriate medicine use in Africa. Expert Review of Pharmacoeconomics & Outcomes Research 17:2, pages 149-152.
Read now
Read now
Sandra C Buttigieg, Prasanta K Dey & Dorothy Gauci. (2016) Business process management in health care: current challenges and future prospects. Innovation and Entrepreneurship in Health 3, pages 1-13.
Read now
Read now
Chia-Ying Lee, Xiaohan Chen, Robert J. Romanelli & Jodi B. Segal. (2016) Forces influencing generic drug development in the United States: a narrative review. Journal of Pharmaceutical Policy and Practice 9:1.
Read now
Read now
Joseph O Fadare, Adekunle O. Adeoti, Olufemi O. Desalu, Okezie O. Enwere, Aliyu M. Makusidi, Olayinka Ogunleye, Taofiki A. Sunmonu, Ilse Truter, Onyinye O Akunne & Brian Godman. (2016) The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians. Expert Review of Pharmacoeconomics & Outcomes Research 16:5, pages 639-650.
Read now
Read now
L. P. Thai, J. R. Moss, B. Godman & A. I. Vitry. (2016) Cost driver analysis of statin expenditure on Australia’s Pharmaceutical Benefits Scheme. Expert Review of Pharmacoeconomics & Outcomes Research 16:3, pages 419-433.
Read now
Read now
Hye-Young Kwon, Hyungmin Kim, Brian Godman & Michael R Reich. (2015) The impact of South Korea’s new drug-pricing policy on market competition among off-patent drugs. Expert Review of Pharmacoeconomics & Outcomes Research 15:6, pages 1007-1014.
Read now
Read now
Pieter Dylst, Arnold Vulto & Steven Simoens. (2015) Societal value of generic medicines beyond cost-saving through reduced prices. Expert Review of Pharmacoeconomics & Outcomes Research 15:4, pages 701-711.
Read now
Read now
Rabiatul Salmi Md Rezal, Mohamed Azmi Hassali, Alian A Alrasheedy, Fahad Saleem, Faridah Aryani Md Yusof & Brian Godman. (2015) Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature. Expert Review of Anti-infective Therapy 13:5, pages 665-680.
Read now
Read now
Brian Godman, Iain Bishop, Stephen M Campbell, Rickard E Malmström & Ilse Truter. (2015) Quality and efficiency of statin prescribing across countries with a special focus on South Africa; findings and future implications. Expert Review of Pharmacoeconomics & Outcomes Research 15:2, pages 323-330.
Read now
Read now
Jurij Fürst, Milan Čižman, Jana Mrak, Damjan Kos, Stephen Campbell, Samuel Coenen, Lars L Gustafsson, Luka Fürst & Brian Godman. (2015) The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications. Expert Review of Anti-infective Therapy 13:2, pages 279-289.
Read now
Read now
Wenjie Zeng, Lars L Gustafsson, Marion Bennie, Alexander E Finlayson & Brian Godman. (2015) Review of ongoing initiatives to improve prescribing efficiency in China; angiotensin receptor blockers as a case history. Expert Review of Pharmacoeconomics & Outcomes Research 15:1, pages 157-169.
Read now
Read now
Panagiotis Petrou. (2014) The power of r – pharmaceutical sales decomposition in Cyprus public healthcare sector and determinants of drug expenditure evolution: any lessons learned?. Expert Review of Pharmacoeconomics & Outcomes Research 14:2, pages 289-300.
Read now
Read now
Brian Godman, Iain Bishop, Alexander E Finlayson, Stephen Campbell, Hye-Young Kwon & Marion Bennie. (2013) Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 13:4, pages 469-482.
Read now
Read now
Jessica Fraeyman, Guido Van Hal, Brian Godman & Philippe Beutels. (2013) The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium. Expert Review of Pharmacoeconomics & Outcomes Research 13:1, pages 141-151.
Read now
Read now
Pieter Dylst, Arnold Vulto & Steven Simoens. (2013) Demand-side policies to encourage the use of generic medicines: an overview. Expert Review of Pharmacoeconomics & Outcomes Research 13:1, pages 59-72.
Read now
Read now
Anna Bucsics, Brian Godman, Thomas Burkhardt, Manuela Schmitzer & Rickard E Malmström. (2012) Influence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 12:6, pages 809-819.
Read now
Read now
Vanda Markovic-Pekovic, Ranko Škrbić, Brian Godman & Lars L Gustafsson. (2012) Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions. Expert Review of Pharmacoeconomics & Outcomes Research 12:5, pages 661-671.
Read now
Read now
Brian Godman, Ken Paterson, Rickard E Malmström, Gisbert Selke, Jean-Paul Fagot & Jana Mrak. (2012) Improving the managed entry of new medicines: sharing experiences across Europe. Expert Review of Pharmacoeconomics & Outcomes Research 12:4, pages 439-441.
Read now
Read now
J Fraeyman, G Van Hal, H De Loof, R Remmen, GRY De Meyer & P Beutels. (2012) POTENTIAL IMPACT OF POLICY REGULATION AND GENERIC COMPETITION ON SALES OF CHOLESTEROL LOWERING MEDICATION, ANTIDEPRESSANTS AND ACID BLOCKING AGENTS IN BELGIUM. Acta Clinica Belgica 67:3, pages 160-171.
Read now
Read now
AG Dupont. (2012) IMPACT OF POLICY MEASURES AND GENERIC COMPETITION ON PHARMACEUTICAL EXPENDITURE IN BELGIUM. Acta Clinica Belgica 67:3, pages 151-153.
Read now
Read now
Ljiljana Sovic Brkicic, Brian Godman, Luka Voncina, Slavica Sovic & Maja Relja. (2012) Initiatives to improve prescribing efficiency for drugs to treat Parkinson’s disease in Croatia: influence and future directions. Expert Review of Pharmacoeconomics & Outcomes Research 12:3, pages 373-384.
Read now
Read now
Marion Bennie, Brian Godman, Iain Bishop & Stephen Campbell. (2012) Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland. Expert Review of Pharmacoeconomics & Outcomes Research 12:1, pages 125-130.
Read now
Read now
Mohammed Abuelkhair, Shajahan Abdu, Brian Godman, Sahar Fahmy, Rickard E Malmström & Lars L Gustafsson. (2012) Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi. Expert Review of Pharmacoeconomics & Outcomes Research 12:1, pages 115-124.
Read now
Read now
Luka Vončina, Tihomir Strizrep, Brian Godman, Marion Bennie, Iain Bishop, Stephen Campbell, Vera Vlahović-Palčevski & Lars L Gustafsson. (2011) Influence of demand-side measures to enhance renin–angiotensin prescribing efficiency in Europe: implications for the future. Expert Review of Pharmacoeconomics & Outcomes Research 11:4, pages 469-479.
Read now
Read now
Kristina Garuoliene, Brian Godman, Jolanta Gulbinovič, Björn Wettermark & Alan Haycox. (2011) European countries with small populations can obtain low prices for drugs: Lithuania as a case history. Expert Review of Pharmacoeconomics & Outcomes Research 11:3, pages 343-349.
Read now
Read now
Brian Godman, Solveig Sakshaug, Christian Berg, Björn Wettermark & Alan Haycox. (2011) Combination of prescribing restrictions and policies to engineer low prices to reduce reimbursement costs. Expert Review of Pharmacoeconomics & Outcomes Research 11:1, pages 121-129.
Read now
Read now
Articles from other publishers (74)
Eric C. Barat, Marianne L.E. Arrii, Annaelle Soubieux-Bourbon, Mikaël Daouphars, Rémi Varin & Patrick R. Tilleul. (2023) Cost effectiveness of using trastuzumab biosimilars compared to trastuzumab original drugs to treat breast cancer in a hospital setting. The Breast 72, pages 103588.
Crossref
Crossref
Johanna C Meyer, Sean MacBride-Stewart, Joseph O Fadare, Ammar Abdulrahman Jairoun, Mainul Haque, Amos Massele, Santosh Kumar, Israel Abebrese Sefah, Phumzile P Skosana & Brian Godman. (2022) Key Considerations From a Health Authority Perspective When Proton Pump Inhibitors Are Used to Treat Gastroesophageal Reflux Disease (GERD) and Their Implications. Cureus.
Crossref
Crossref
Sinenhlanhla Pearl Guma, Brian Godman, Stephen M. Campbell & Ozayr Mahomed. (2022) Determinants of the Empiric Use of Antibiotics by General Practitioners in South Africa: Observational, Analytic, Cross-Sectional Study. Antibiotics 11:10, pages 1423.
Crossref
Crossref
Emad S Aljahdli, Aseel M Mokhtar, Saad A Aljehani, Raad M Hamdi, Baraa H Alsubhi, Khaild F Aljuhani, Khaled A Saleh, Ammar D Alzoriri & Waleed S Alghamdi. (2022) Assessment of Awareness and Knowledge of Proton Pump Inhibitors Among the General Population in Saudi Arabia. Cureus.
Crossref
Crossref
Magdalena Zielińska & Tomasz Hermanowski. (2022) Sources of Information on Medicinal Products Among Physicians – A Survey Conducted Among Primary Care Physicians in Poland. Frontiers in Pharmacology 12.
Crossref
Crossref
Xiaotong Wen, Shicheng Yin, Lanyue Cui, Lining Mao, Zhaoyu Lin, Zilalai Yaermaimaiti, Xin Geng, Yingxia Li, Ying Yang, Dan Cui & Zongfu Mao. (2021) The Effects of the National Centralized Drug Purchasing Pilot Program on Nucleos(t)ide Analogs in Shenzhen City: An Interrupted Time Series Analysis. Frontiers in Public Health 9.
Crossref
Crossref
Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, Amanj Kurdi, Eleonora Allocati, Mihajlo Jakovljevic, Francis Kalemeera, Iris Hoxha, Anna Nachtnebel, Robert Sauermann, Manfred Hinteregger, Vanda Marković-Peković, Biljana Tubic, Guenka Petrova, Konstantin Tachkov, Juraj Slabý, Radka Nejezchlebova, Iva Selke Krulichová, Ott Laius, Gisbert Selke, Irene Langner, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuolienė, Jolanta Gulbinovič, Patricia Vella Bonanno, Jakub Rutkowski, Skule Ingeberg, Øyvind Melien, Ileana Mardare, Jurij Fürst, Sean MacBride-Stewart, Carol Holmes, Caridad Pontes, Corinne Zara, Marta Turu Pedrola, Mikael Hoffmann, Vasileios Kourafalos, Alice Pisana, Rita Banzi, Stephen Campbell & Bjorn Wettermark. (2021) Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications. BioMed Research International 2021, pages 1-16.
Crossref
Crossref
Wei-jie Li, Mei-jun Xia, Shi-wei Gong & Yu-feng Ding. (2021) Perceptions of Generic Drugs in the Pharmacists of Public Hospitals: A Cross-sectional Survey in Hubei Province of China. Current Medical Science 41:5, pages 987-995.
Crossref
Crossref
Brian Godman, Joseph Fadare, Hye-Young Kwon, Carolina Zampirolli Dias, Amanj Kurdi, Isabella Piassi Dias Godói, Dan Kibuule, Iris Hoxha, Sylvia Opanga, Zikria Saleem, Tomasz Bochenek, Vanda Marković-Peković, Ileana Mardare, Aubrey C Kalungia, Stephen Campbell, Eleonora Allocati, Alice Pisana, Antony P Martin & Johanna C Meyer. (2021) Evidence-based public policy making for medicines across countries: findings and implications for the future. Journal of Comparative Effectiveness Research 10:12, pages 1019-1052.
Crossref
Crossref
Brian Godman, Mainul Haque, Trudy Leong, Eleonora Allocati, Santosh Kumar, Salequl Islam, Jaykaran Charan, Farhana Akter, Amanj Kurdi, Carlos Vassalo, Muhammed Abu Bakar, Sagir Abdur Rahim, Nusrat Sultana, Farzana Deeba, M. A. Halim Khan, A. B. M. Muksudul Alam, Iffat Jahan, Zubair Mahmood Kamal, Humaira Hasin, Munzur-E-Murshid, Shamsun Nahar, Monami Haque, Siddhartha Dutta, Jha Pallavi Abhayanand, Rimple Jeet Kaur, Godfrey Mutashambara Rwegerera, Renata Cristina Rezende Macedo do Nascimento, Isabella Piassi Dias Godói, Mohammed Irfan, Adefolarin A. Amu, Patrick Matowa, Joseph Acolatse, Robert Incoom, Israel Abebrese Sefah, Jitendra Acharya, Sylvia Opanga, Lisper Wangeci Njeri, David Kimonge, Hye-Young Kwon, SeungJin Bae, Karen Koh Pek Khuan, Abdullahi Rabiu Abubakar, Ibrahim Haruna Sani, Tanveer Ahmed Khan, Shahzad Hussain, Zikria Saleem, Oliver Ombeva Malande, Thereza Piloya-Were, Rosana Gambogi, Carla Hernandez Ortiz, Luke Alutuli, Aubrey Chichonyi Kalungia, Iris Hoxha, Vanda Marković-Peković, Biljana Tubic, Guenka Petrova, Konstantin Tachkov, Ott Laius, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuoliene, Jolanta Gulbinovič, Magdalene Wladysiuk, Jakub Rutkowski, Ileana Mardare, Jurij Fürst, Stuart McTaggart, Sean MacBride-Stewart, Caridad Pontes, Corinne Zara, Eunice Twumwaa Tagoe, Rita Banzi, Janney Wale & Mihajlo Jakovljevic. (2021) The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future. Frontiers in Public Health 9.
Crossref
Crossref
Cormac Kennedy, Amelia Smith, Eoin O’Brien, Jamie Rice & Michael Barry. (2021) Prescribers’ knowledge of drug costs: a contemporary Irish study. Drugs & Therapy Perspectives 37:6, pages 272-281.
Crossref
Crossref
Roland Nnaemeka Okoro. (2021) Biosimilar medicines uptake: The role of the clinical pharmacist. Exploratory Research in Clinical and Social Pharmacy 1, pages 100008.
Crossref
Crossref
Su-Yeon Yu, Boram Lee, Treasure M. McGuire, Hye-Jae Lee & Samantha A. Hollingworth. (2019) Consumption of medicines used for gastric acid-related disorders in Australia and South Korea: a cross-country comparison. European Journal of Clinical Pharmacology 76:4, pages 547-555.
Crossref
Crossref
Georgia Casanova, Andrea Principi & Giovanni Lamura. (2020) Social Innovation in Long-Term Care: Lessons from the Italian Case. International Journal of Environmental Research and Public Health 17:7, pages 2367.
Crossref
Crossref
Mohamed Gad, Ahmed Salem, Wija Oortwijn, Ruaraidh Hill & Brian Godman. (2020) Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions. Frontiers in Pharmacology 11.
Crossref
Crossref
Hongli Luo, Qingze Fan, Tierong Bian, Xiuying Li, Kun Chen, Qingbi Zhang, Yuting Wei, Yang Xiao & Yan Li. (2019) Awareness, attitude and behavior regarding proton pump inhibitor among medical staff in the Southwest of China. BMC Health Services Research 19:1.
Crossref
Crossref
Fatemeh Soleymani, Brian Godman, Pegah Yarimanesh & Abbas Kebriaeezadeh. (2019) Prescribing patterns of physicians working in both the direct and indirect treatment sectors in Iran; findings and implications. Journal of Pharmaceutical Health Services Research 10:4, pages 407-413.
Crossref
Crossref
Seung-Mi Lee, Jae-Ho Jung, David Suh, Yu-Seon Jung, Seung-Lai Yoo, Dong-Won Kim, Ji-An Kim & Dong-Churl Suh. (2019) Budget Impact of Switching to Biosimilar Trastuzumab (CT-P6) for the Treatment of Breast Cancer and Gastric Cancer in 28 European Countries. BioDrugs 33:4, pages 423-436.
Crossref
Crossref
Angela Acosta, Egdda Patricia Vanegas, Joan Rovira, Brian Godman & Tomasz Bochenek. (2019) Medicine Shortages: Gaps Between Countries and Global Perspectives. Frontiers in Pharmacology 10.
Crossref
Crossref
Brian Godman, Amanj Kurdi, Holly McCabe, Chris F Johnson, Corrado Barbui, Sean MacBride-Stewart, Simon Hurding, Axel Leporowski, Marion Bennie & Alec Morton. (2019) Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence. Journal of Comparative Effectiveness Research 8:7, pages 535-547.
Crossref
Crossref
Hye-Young Kwon, Seungjin Bae, Sang-eun Choi, Sylvia Park, Eui-Kyung Lee, Sungmin Park & Jinhyun Kim. (2019) Easy cuts, easy rebound: Drug expenditures with massive price cuts in Korea. Health Policy 123:4, pages 388-392.
Crossref
Crossref
Brian Godman, Anna Bucsics, Patricia Vella Bonanno, Wija Oortwijn, Celia C. Rothe, Alessandra Ferrario, Simone Bosselli, Andrew Hill, Antony P. Martin, Steven Simoens, Amanj Kurdi, Mohamed Gad, Jolanta Gulbinovič, Angela Timoney, Tomasz Bochenek, Ahmed Salem, Iris Hoxha, Robert Sauermann, Amos Massele, Augusto Alfonso GuerraJr.Jr., Guenka Petrova, Zornitsa Mitkova, Gnosia Achniotou, Ott Laius, Catherine Sermet, Gisbert Selke, Vasileios Kourafalos, John Yfantopoulos, Einar Magnusson, Roberta Joppi, Margaret Oluka, Hye-Young Kwon, Arianit Jakupi, Francis Kalemeera, Joseph O. Fadare, Oyvind Melien, Maciej Pomorski, Magdalene Wladysiuk, Vanda Marković-Peković, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Dominik Tomek, Corrine Zara, Eduardo Diogene, Johanna C. Meyer, Rickard Malmström, Björn Wettermark, Zinhle Matsebula, Stephen Campbell & Alan Haycox. (2018) Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets. Frontiers in Public Health 6.
Crossref
Crossref
Cristina Mondelo-García, Elvia Mendoza, María-Jesús Movilla-Fernández & Carmen Coronado. (2018) Perceptions of pharmacists and physicians on generic substitution in a financial crisis context in Northwestern Spain: A qualitative study. Health Policy 122:12, pages 1316-1325.
Crossref
Crossref
Seda Kumru & Mehmet Top. (2018) Pricing and reimbursement of generic pharmaceuticals in Turkey: Evaluation of hypertension drugs from 2007 to 2013. Health Policy and Technology 7:2, pages 182-193.
Crossref
Crossref
M. Al Hussaini, N. Alsaffar & A. Abdulraheem. (2018) Exploring community pharmacists’ knowledge, perception and experiences towards branded and generic medicines in Kuwait: Highlighting the role of pharmacist. Bulletin of Faculty of Pharmacy, Cairo University 56:1, pages 109-114.
Crossref
Crossref
Ljubica Bojanić, Vanda Marković-Peković, Ranko Škrbić, Nataša Stojaković, Mirjana Ðermanović, Janja Bojanić, Jurij Fürst, Amanj B. Kurdi & Brian Godman. (2018) Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications. Frontiers in Pharmacology 9.
Crossref
Crossref
Tomasz Bochenek, Vafa Abilova, Ali Alkan, Bogdan Asanin, Iñigo de Miguel Beriain, Zeljka Besovic, Patricia Vella Bonanno, Anna Bucsics, Michal Davidescu, Elfi De Weerdt, Natasa Duborija-Kovacevic, Jurij Fürst, Mina Gaga, Elma Gailīte, Jolanta Gulbinovič, Emre U. Gürpınar, Balázs Hankó, Vincent Hargaden, Tor A. Hotvedt, Iris Hoxha, Isabelle Huys, Andras Inotai, Arianit Jakupi, Helena Jenzer, Roberta Joppi, Ott Laius, Marie-Camille Lenormand, Despina Makridaki, Admir Malaj, Kertu Margus, Vanda Marković-Peković, Nenad Miljković, João L. de Miranda, Stanislav Primožič, Dragana Rajinac, David G. Schwartz, Robin Šebesta, Steven Simoens, Juraj Slaby, Ljiljana Sović-Brkičić, Tomas Tesar, Leonidas Tzimis, Ewa Warmińska & Brian Godman. (2018) Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries. Frontiers in Pharmacology 8.
Crossref
Crossref
N. Maniadakis, G. Kourlaba, J. Shen & A. Holtorf. (2017) Comprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status. BMC Health Services Research 17:1.
Crossref
Crossref
Jaran Eriksen, Lars L Gustafsson, Kristina Ateva, Pia Bastholm-Rahmner, Marie-Louise Ovesjö, Malena Jirlow, Maria Juhasz-Haverinen, Gerd Lärfars, Rickard E Malmström, Björn Wettermark & Eva Andersén-Karlsson. (2017) High adherence to the ‘Wise List’ treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines. BMJ Open 7:4, pages e014345.
Crossref
Crossref
Richard Ofori-Asenso & Akosua Agyeman. (2016) Irrational Use of Medicines—A Summary of Key Concepts. Pharmacy 4:4, pages 35.
Crossref
Crossref
Winnie de Bruijn, Cristina Ibáñez, Pia Frisk, Hanne Bak Pedersen, Ali Alkan, Patricia Vella Bonanno, Ljiljana S. Brkičić, Anna Bucsics, Guillaume Dedet, Jaran Eriksen, Joseph O. Fadare, Jurij Fürst, Gisselle Gallego, Isabella P. Godói, Augusto A. Guerra Júnior, Hakkı Gürsöz, Saira Jan, Jan Jones, Roberta Joppi, Saim Kerman, Ott Laius, Newman Madzikwa, Einar Magnússon, Mojca Maticic, Vanda Markovic-Pekovic, Amos Massele, Olayinka Ogunleye, Aisling O'Leary, Jutta Piessnegger, Catherine Sermet, Steven Simoens, Celda Tiroyakgosi, Ilse Truter, Magnus Thyberg, Kristina Tomekova, Magdalena Wladysiuk, Sotiris Vandoros, Elif H. Vural, Corinne Zara & Brian Godman. (2016) Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future. Frontiers in Pharmacology 7.
Crossref
Crossref
Juliana de Oliveira Costa, Celline Cardoso Almeida-Brasil, Brian Godman, Michael Adam Fischer, Jonathan Dartnell, Aine Heaney, Carolina Greco Bernardes dos Santos, Francisco de Assis Acurcio, Juliana Álvares & Augusto Afonso GuerraJrJr. (2016) Implementation of clinical guidelines in Brazil: should academic detailing be used?. Journal of Pharmaceutical Health Services Research 7:2, pages 105-115.
Crossref
Crossref
Shinobu Imai, Karolina Andersson Sundell & Kiyohide Fushimi. (2016) Comparison of pharmaceutical policies to stimulate use of generics in Japan and Sweden. Health Policy and Technology 5:2, pages 189-195.
Crossref
Crossref
Elisabetta Poluzzi, Giacomo Veronese, Carlo Piccinni, Emanuel Raschi, Ariola Koci, Paola Pagano, Brian Godman, Giulio Marchesini, Giuseppe Boriani & Fabrizio De Ponti. (2016) Switching among Equivalents in Chronic Cardiovascular Therapies: ‘Real World’ Data from Italy. Basic & Clinical Pharmacology & Toxicology 118:1, pages 63-69.
Crossref
Crossref
Wenjie Zeng, Alexander E Finlayson, Sushma Shankar, Winnie de Bruyn & Brian Godman. (2015) Prescribing efficiency of proton pump inhibitors in China: influence and future directions. BMC Health Services Research 15:1.
Crossref
Crossref
Bonny Parkinson, Catherine Sermet, Fiona Clement, Steffan Crausaz, Brian Godman, Sarah Garner, Moni Choudhury, Sallie-Anne Pearson, Rosalie Viney, Ruth Lopert & Adam G. Elshaug. (2015) Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. PharmacoEconomics 33:9, pages 905-924.
Crossref
Crossref
Heli Halava, Hugo Westerlund, Maarit Jaana Korhonen, Jaana Pentti, Mika Kivimäki, Linnea Kjeldgård, Kristina Alexanderson & Jussi Vahtera. (2015) Influence of Retirement on Adherence to Statins in the Insurance Medicine All-Sweden Total Population Data Base. PLOS ONE 10:6, pages e0130901.
Crossref
Crossref
Amanj Baker, Li-Chia Chen, Rachel A. Elliott & Brian Godman. (2015) The impact of the ‘Better Care Better Value’ prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental design. BMC Health Services Research 15:1.
Crossref
Crossref
Osamu Takizawa, Hisashi Urushihara, Shiro Tanaka & Koji Kawakami. (2015) Price difference as a predictor of the selection between brand name and generic statins in Japan. Health Policy 119:5, pages 612-619.
Crossref
Crossref
Georg Heinze, Milan Hronsky, Berthold Reichardt, Christoph Baumgärtel, Marcus Müllner, Anna Bucsics & Wolfgang C. Winkelmayer. (2014) Potential Savings in Prescription Drug Costs for Hypertension, Hyperlipidemia, and Diabetes Mellitus by Equivalent Drug Substitution in Austria: A Nationwide Cohort Study. Applied Health Economics and Health Policy 13:2, pages 193-205.
Crossref
Crossref
Petros Pechlivanoglou, Jaap E. Wieringa, Tim de Jager & Maarten J. Postma. (2015) The Effect of Financial and Educational Incentives on Rational Prescribing. A State-Space Approach. Health Economics 24:4, pages 439-453.
Crossref
Crossref
Ilse Truter, Sushma Shankar, Marion Bennie, Menno van Woerkom & Brian Godman. (2015) Initiatives in South Africa to enhance the prescribing of generic proton pump inhibitors: findings and implications. Journal of Comparative Effectiveness Research 4:2, pages 123-131.
Crossref
Crossref
Zoltán Kaló, Anke-Peggy Holtorf, Rafael Alfonso-Cristancho, Jie Shen, Tamás Ágh, András Inotai & Diana Brixner. (2015) Need for Multicriteria Evaluation of Generic Drug Policies. Value in Health 18:2, pages 346-351.
Crossref
Crossref
Mohamed Azmi Hassali, Alian A. Alrasheedy, Andrew McLachlan, Tuan Anh Nguyen, Saleh Karamah AL-Tamimi, Mohamed Izham Mohamed Ibrahim & Hisham Aljadhey. (2014) The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use. Saudi Pharmaceutical Journal 22:6, pages 491-503.
Crossref
Crossref
James C. Moon, Brian Godman, Max Petzold, Samantha Alvarez-Madrazo, Kathleen Bennett, Iain Bishop, Anna Bucsics, Ulrik Hesse, Andrew Martin, Steven Simoens, Corinne Zara & Rickard E. Malmström. (2014) Different initiatives across Europe to enhance losartan utilization post generics: impact and implications. Frontiers in Pharmacology 5.
Crossref
Crossref
Pili Ferrer, Elena Ballarín, Mònica Sabaté, Joan-Ramon Laporte, Marieke Schoonen, Marietta Rottenkolber, Joan Fortuny, Joerg Hasford, Iain Tatt & Luisa Ibáñez. (2014) Sources of European drug consumption data at a country level. International Journal of Public Health 59:5, pages 877-887.
Crossref
Crossref
Wenjie Zeng, Junjie Zhen, Mengying Feng, Stephen M Campbell, Alexander E Finlayson & Brian Godman. (2014) Analysis of the influence of recent reforms in China: cardiovascular and cerebrovascular medicines as a case history to provide future direction. Journal of Comparative Effectiveness Research 3:4, pages 371-386.
Crossref
Crossref
Michael Due Larsen, Mette Schou, Anja Sparre Kristiansen & Jesper Hallas. (2014) The influence of hospital drug formulary policies on the prescribing patterns of proton pump inhibitors in primary care. European Journal of Clinical Pharmacology 70:7, pages 859-865.
Crossref
Crossref
Andrew Martin, Brian GodmanJamilette Miranda, Jeanette Tilstone, Nigget Saleem, Erika Olsson, Angela Acosta, Luis Restrepo & Marion Bennie. (2014) Measures to improve angiotensin receptor blocker prescribing efficiency in the UK: findings and implications. Journal of Comparative Effectiveness Research 3:1, pages 41-51.
Crossref
Crossref
Sarah J. Mansfield. (2014) Generic drug prices and policy in Australia: room for improvement? A comparative analysis with England. Australian Health Review 38:1, pages 6.
Crossref
Crossref
. 2014. Aplicación del análisis coste-efectividad de los medicamentos y los programas de salud en la planificación sanitaria. Aplicación del análisis coste-efectividad de los medicamentos y los programas de salud en la planificación sanitaria
133
140
.
Suzanne Dunne, Bill Shannon, Colum Dunne & Walter Cullen. (2013) A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacology and Toxicology 14:1.
Crossref
Crossref
Brian Godman, Alexander E Finlayson, Parneet K Cheema, Eva Zebedin-Brandl, Inaki Gutiérrez-Ibarluzea, Jan Jones, Rickard E Malmström, Elina Asola, Christoph Baumgärtel, Marion Bennie, Iain Bishop, Anna Bucsics, Stephen Campbell, Eduardo Diogene, Alessandra Ferrario, Jurij Fürst, Kristina Garuoliene, Miguel Gomes, Katharine Harris, Alan Haycox, Harald Herholz, Krystyna Hviding, Saira Jan, Marija Kalaba, Christina Kvalheim, Ott Laius, Sven-Ake Lööv, Kamila Malinowska, Andrew Martin, Laura McCullagh, Fredrik Nilsson, Ken Paterson, Ulrich Schwabe, Gisbert Selke, Catherine Sermet, Steven Simoens, Dominik Tomek, Vera Vlahovic-Palcevski, Luka Voncina, Magdalena Wladysiuk, Menno van Woerkom, Durhane Wong-Rieger, Corrine Zara, Raghib Ali & Lars L Gustafsson. (2013) Personalizing health care: feasibility and future implications. BMC Medicine 11:1.
Crossref
Crossref
Ulrik Hesse, Brian Godman, Max Petzold, Andrew Martin & Rickard E. Malmström. (2013) Impact of Delisting ARBs, Apart from Losartan, on ARB Utilisation Patterns in Denmark: Implications for Other Countries. Applied Health Economics and Health Policy 11:6, pages 677-685.
Crossref
Crossref
Brian Godman, Kristien De Bruyn, Jamilette Miranda, Emanuel Raschi, Marion Bennie, Corrado Barbui & Steven Simoens. (2013) Generic atypical antipsychotic drugs in Belgium: their influence and implications. Journal of Comparative Effectiveness Research 2:6, pages 551-561.
Crossref
Crossref
Hye-Young Kwon, Ji-Min Hong, Brian Godman & Bong-Min Yang. (2013) Price cuts and drug spending in South Korea: The case of antihyperlipidemic agents. Health Policy 112:3, pages 217-226.
Crossref
Crossref
Dong-Sook Kim, Seungjin Bae & Sunmee Jang. (2013) Lessons from Generic Promotion Policies in Other Countries. Health Policy and Management 23:3, pages 210-223.
Crossref
Crossref
Brian Godman, Marie Persson, Jamilette Miranda, Corrado Barbui, Marion Bennie, Alexander E Finlayson, Emanuel Raschi & Bjorn Wettermark. (2013) Can authorities take advantage of the availability of generic atypical antipsychotic drugs? Findings from Sweden and potential implications. Journal of Pharmaceutical Health Services Research 4:3, pages 139-150.
Crossref
Crossref
Steven Simoens, Kristien De Bruyn, Jamilette Miranda, Marion Bennie, Rickard E. Malmström & Brian Godman. (2013) Measures to enhance angiotensin-receptor blocker prescribing efficiency in Belgium following generic losartan: impact and implications for the future. Journal of Pharmaceutical Health Services Research 4:3, pages 173-181.
Crossref
Crossref
Brian Godman, Marie Persson, Jamilette Miranda, Peter Skiöld, Björn Wettermark, Corrado Barbui & Lars L. Gustafsson. (2013) Changes in the Utilization of Venlafaxine after the Introduction of Generics in Sweden. Applied Health Economics and Health Policy 11:4, pages 383-393.
Crossref
Crossref
Salih Mollahaliloglu, Ali Alkan, Basak Donertas, Senay Ozgulcu & Ahmet Akici. (2013) Assessment of antibiotic prescribing at different hospitals and primary health care facilities. Saudi Pharmaceutical Journal 21:3, pages 281-291.
Crossref
Crossref
Sylvain Pichetti, Catherine Sermet, Brian Godman, Stephen M. Campbell & Lars L. Gustafsson. (2013) Multilevel Analysis of the Influence of Patients’ and General Practitioners’ Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France. Applied Health Economics and Health Policy 11:3, pages 205-218.
Crossref
Crossref
M. Bennie, I. Bishop, B. Godman, C. Barbui, E. Raschi, S. Campbell, J. Miranda & L. L. Gustafsson. (2013) Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications. International Journal of Clinical Practice 67:2, pages 170-180.
Crossref
Crossref
Brian Godman & Lars L. Gustafsson. (2013) A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing. Applied Health Economics and Health Policy 11:1, pages 79-82.
Crossref
Crossref
Steven Simoens & Peter R. Sinnaeve. (2012) Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin Therapy. Cardiovascular Drugs and Therapy 27:1, pages 49-60.
Crossref
Crossref
Caitriona Cahir, Tom Fahey, Lesley Tilson, Conor Teljeur & Kathleen Bennett. (2012) Proton pump inhibitors: potential cost reductions by applying prescribing guidelines. BMC Health Services Research 12:1.
Crossref
Crossref
Marija KalabaBrian Godman, Aleksandar Vuksanović, Marion Bennie & Richard E Malmström. (2012) Possible ways to enhance renin–angiotensin prescribing efficiency: Republic of Serbia as a case history?. Journal of Comparative Effectiveness Research 1:6, pages 539-549.
Crossref
Crossref
Menno van Woerkom, Hans Piepenbrink, Brian GodmanJoost de Metz, Stephen Campbell, Marion Bennie, Marietta Eimers & Lars L Gustafsson. (2012) Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications. Journal of Comparative Effectiveness Research 1:6, pages 527-538.
Crossref
Crossref
Warren A. Kaplan, Lindsay Sarah Ritz, Marie Vitello & Veronika J. Wirtz. (2012) Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000–2010. Health Policy 106:3, pages 211-224.
Crossref
Crossref
M. S. Aapro. (2012) What do prescribers think of biosimilars?. Targeted Oncology 7:S1, pages 51-55.
Crossref
Crossref
Billie Pettersson, Mikael Hoffmann, Per Wändell & Lars-Åke Levin. (2012) Utilization and costs of lipid modifying therapies following health technology assessment for the new reimbursement scheme in Sweden. Health Policy 104:1, pages 84-91.
Crossref
Crossref
Sylvain Pichetti, Christine Sorasith & Catherine Sermet. (2011) Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on prescription rates: A time-series analysis for France 1998–2010. Health Policy 102:2-3, pages 159-169.
Crossref
Crossref
M. S. Aapro. (2011) What does a prescriber think of biosimilars?Biosimilaires: qu’en pense le prescripteur ?. Oncologie 13:5, pages 234-238.
Crossref
Crossref
Lars L. Gustafsson, Björn Wettermark, Brian Godman, Eva Andersén-Karlsson, Ulf Bergman, Jan Hasselström, Lars-Olof Hensjö, Paul Hjemdahl, Ingrid Jägre, Margaretha Julander, Bo Ringertz, Daniel Schmidt, Susan Sjöberg, Folke Sjöqvist, Carl-Olav Stiller, Elisabeth Törnqvist, Rolf Tryselius, Sigurd Vitols & Christer von Bahr. (2011) The ‘Wise List’- A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm. Basic & Clinical Pharmacology & Toxicology 108:4, pages 224-233.
Crossref
Crossref